Stock NRBO NEUROBO PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar NeuroBo Pharmaceuticals, Inc.

Equities

NRBO

US64132R4048

Market Closed - Nasdaq
Other stock markets
 04:30:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
3.14 USD +2.61% Intraday chart for NeuroBo Pharmaceuticals, Inc. -6.82% -15.06%
Apr. 17 Sector Update: Health Care Stocks Mixed Wednesday Afternoon MT
Apr. 17 NeuroBo Begins Dosing in Phase 1 Study of Obesity Treatment; Shares Rise MT

Chart calendar NeuroBo Pharmaceuticals, Inc.

1d4.gstMP2eUVEs7NnMu3Cy3joFgTnleC4BurZVs9SDpJck.sfoqTV_wC38PcBBk7WOB2eYxDBM2abUX2Nkjj2aZZJbwpRMKANYxMk9-Ig~ece593000929998dcacc7e8510f7d26e

Upcoming events on NeuroBo Pharmaceuticals, Inc.

2024-08-12 Q2 2024 Earnings Release (Projected)
2024-11-10 Q3 2024 Earnings Release (Projected)
2025-03-26 Q4 2024 Earnings Release (Projected)
2025-08-18 Q2 2025 Earnings Release (Projected)

Past events on NeuroBo Pharmaceuticals, Inc.

2024-03-28 08:01 am Q4 2023 Earnings Release
2024-02-25 BIO CEO & Investor Conference
2024-01-15 Biotech Showcase
2024-01-03 NASH-TAG Conference
2023-12-14 11:00 am OTC Markets Group Life Science Investor Forum
2023-12-07 11:00 am Investor Summit Virtual Conference
2023-11-13 04:05 pm Q3 2023 Earnings Release
2023-10-24 02:30 pm H.C. Wainwright NASH Investor Conference
2023-08-09 04:05 pm Q2 2023 Earnings Release
2023-06-27 Annual General Meeting
2023-06-26 02:30 pm American Diabetes Association Scientific Session - Poster No 1668
2023-06-26 02:30 pm American Diabetes Association Scientific Session - Poster No 1676
2023-06-25 03:10 pm American Diabetes Association Scientific Session - Poster No1668
2023-03-30 04:40 pm Q4 2022 Earnings Release
2022-12-21 Extraordinary Shareholders Meeting
2022-06-09 10:00 am Annual General Meeting
2022-04-01 08:00 am FY 2021 Earnings Release
2021-11-15 08:00 am Q3 2021 Earnings Release
2021-08-17 Extraordinary Shareholders Meeting - M&A Vote
2021-08-16 08:00 am Interim 2021 Earnings Release

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00


0,00
0,00
- 		0,00
0,00
-
0,00

EBITDA
Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00


0,00
0,00
- 		0,00
0,00
-
0,00

EBIT
Million USD		Released
Forecast
Spread 		-20,2
-16,6
-21.45%		-29,7
-13,6
-118.48%		0,00


-19,6
-12,2
-61.37%		-15,9
-14,3
-10.9%
-26,2

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-21,3
-16,5
-29.52%		-29,7
-13,6
-118.8%		0,00


-14,0
-12,2
-14.75%		-12,5
-11,2
-11.55%
-26,0

Net income
Million USD		Released
Forecast
Spread 		-21,3
-16,5
-29.52%		-29,7
-13,6
-118.46%		-15,3


-14,0
-12,2
-14.75%		-12,5
-11,2
-11.55%
-26,0

EPS
USD		Released
Forecast
Spread 		-979
-264
-270.91%		-439
-197
-123.17%		-158


-43,4
-92,6
53.07%		-2,46
-2,20
-12.07%
-3,50

Announcement Date30/03/2015/04/2131/03/2230/03/2328/03/24-

Quarterly results

Fiscal PeriodDecember 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD		Released
Forecast
Spread














0,00
0,00
-
0,00


0,00


0,00


0,00

EBIT
Million USD		Released
Forecast
Spread


-10,4
-2,97
-251.77%		-2,52
-2,69
6.39%		-3,81
-3,66
-3.88%		-3,89
-4,35
10.53%		-5,67
-4,12
-37.7%
-5,67


-6,18


-6,83


-7,55

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread


-4,68
-2,97
-57.71%		-2,60
-2,61
0.04%		-0,73
-3,55
79.31%		-3,82
-4,21
9.25%		-5,31
-4,00
-32.82%
-5,61


-6,14


-6,74


-7,48

Net income
Million USD		Released
Forecast
Spread 		-3,11


-4,68
-2,97
-57.71%		-2,60
-2,61
0.04%		-0,73
-3,55
79.31%		-3,82
-4,21
9.25%		-5,31
-4,00
-32.82%
-5,61


-6,14


-6,74


-7,48

EPS
USD		Released
Forecast
Spread 		-28,0



-9,60

-0,48
-5,04
90.48%		-0,16
-1,04
84.62%		-0,72
-0,88
18.18%		-2,28
-0,79
-190.45%
-1,10


-0,85


-0,77


-0,80

Announcement Date14/11/2230/03/2312/05/2309/08/2313/11/2328/03/24----

Upcoming sector events for NeuroBo Pharmaceuticals, Inc.

2024-04-28 HITGEN INC.: Q1 2024 Earnings Release (Projected)
2024-04-28 CASSAVA SCIENCES, INC.: Q1 2024 Earnings Release (Projected)
2024-04-29 DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
2024-04-29 ARVINAS, INC.: Q1 2024 Earnings Release (Projected)
2024-04-29 MABWELL (SHANGHAI) BIOSCIENCE CO., LTD.: Q1 2024 Earnings Release
2024-04-29 WUXI APPTEC CO., LTD.: Q1 2024 Earnings Release
2024-04-30 04:05 pm EXELIXIS, INC.: Q1 2024 Earnings Release
2024-04-30 SUMMIT THERAPEUTICS INC.: Q1 2024 Earnings Release
2024-04-30 MACROGENICS, INC.: Q1 2024 Earnings Release (Projected)
2024-04-30 REGENXBIO INC.: Q1 2024 Earnings Release (Projected)
More events

Past sector events for NeuroBo Pharmaceuticals, Inc.

2024-04-25 INVENTISBIO CO., LIMITED: Q4 2023 Earnings Release
2024-04-25 SHANGHAI MEDICILON INC.: Q1 2024 Earnings Release (Projected)
2024-04-25 SHANGHAI ALLIST PHARMACEUTICALS CO., LTD.: Q1 2024 Earnings Release (Projected)
2024-04-25 DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release (Projected)
2024-04-25 SHANGHAI ALLIST PHARMACEUTICALS CO., LTD.: Q4 2023 Earnings Release
2024-04-25 REMEGEN CO., LTD.: Q1 2024 Earnings Release
2024-04-25 06:30 am SAGE THERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-04-24 JIANGSU YAHONG MEDITECH CO., LTD.: Q1 2024 Earnings Release (Projected)
2024-04-24 BIO-THERA SOLUTIONS, LTD.: Q1 2024 Earnings Release (Projected)
2024-04-24 PTC THERAPEUTICS, INC.: Q1 2024 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. NRBO Stock
  4. Calendar NeuroBo Pharmaceuticals, Inc.